Publications by authors named "F Mergel"

Claim this Profile
S
Study Protocol of SURVIVE HERoes (NCT06643585): Trastuzumab Deruxtecan for molecular relapse in HER2+/ Low early breast cancer with ctDNA positivity after primary therapy.
Kerstin Pfister, Thomas W P Friedl, Andreas Hartkopf, Franziska Mergel, Sophia Huesmann

PLoS One· November 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The SURVIVE study (NCT05658172): Bringing breast cancer aftercare to the 21stcentury: Study protocol of a Phase III clinical trial comparing liquid biopsy guided vs. Standard of care surveillance for intermediate to high-risk breast cancer survivors.
Tatjana Braun, Sophia Huesmann, Kerstin Pfister, Thomas W P Friedl, Andreas Hartkopf, Franziska Mergel

PLoS One· September 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Is Radiographic Aftercare Obsolete? How Testing Positive for ctDNA Can Be a Precedent for Late Relapse, Even in Low-Risk Hormone-Receptor-Positive Breast Cancer.
Kerstin Pfister, Sophia Huesmann, Angelina Fink, Thomas W P Friedl, Franziska Mergel

Int J Mol Sci· September 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Detection of minimal residual disease and prediction of recurrence in breast cancer using a plasma-only circulating tumor DNA assay.
W Janni, B Rack, T W P Friedl, A D Hartkopf, L Wiesmüller, F Mergel

ESMO Open· April 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Do We Need Anthracyclines for Elderly Patients with Triple-Negative Breast Cancer?
Stefan Lukac, Visnja Fink, Thomas W P Friedl, Franziska Mergel, Kerstin Pfister

Breast Care (Basel)· March 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis